Adyn is a precision medicine company that develops personalized birth control methods. It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling users to collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception. Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC.
Allocate is modernizing private markets by providing a platform that offers family offices and individual investors access to a curated network of top-tier private capital funds and direct investment opportunities, particularly in technology and healthcare sectors. With over 100 years of collective experience, Allocate aims to break down barriers for investors, allowing them to discover high-quality deal flow and invest through a user-friendly digital interface. The company has raised a total of $33.5 million in funding and manages over $850 million in assets, positioning itself as a leader in making private alternatives investing more accessible and transparent for a broader set of investors.
Arena Club is a revolutionary platform for collectors, offering a new way to grade, collect, invest, sell, and trade cards. It combines physical and digital experiences, allowing users to showcase their collections in personal online showrooms. The grading process is powered by advanced machine learning, ensuring accuracy and transparency, with all transactions recorded on the blockchain for security. Arena Club aims to eliminate the traditional challenges of card collecting, such as authenticity concerns and shipping hassles, positioning itself as a leading destination for passionate collectors.
Ayble Health is a personalized GI care platform that combines behavioral science and clinical protocols to improve the standard of care for patients with gastrointestinal conditions. The platform offers personalized nutrition plans, a Mind-Gut program, and access to expert GI care teams, all covered by insurance. Ayble Health differentiates itself by being the first gastroenterology company independently evaluated by the Validation Institute and partnering with the American Nutrition Association. The company aims to provide a comprehensive, data-driven ecosystem of support for GI patients, focusing on the whole person rather than just medication.
Beautiful Destinations is a multi-award winning strategy and content creation agency that operates one of the world’s largest and most influential online travel communities. The company specializes in creating engaging content and marketing campaigns for major travel brands, including tourism boards and hospitality companies. With a focus on social media, Beautiful Destinations has built a substantial following of 50 million people across its channels, driving travel inspiration and bookings through high-quality visual storytelling. Their unique approach to content creation, which includes photography, drone, and video, differentiates them in the market, positioning them as a leader in the travel content space.